Skip to content

StrideBio, Inc vs VectorY

StrideBio, Inc logo

StrideBio, Inc

The next evolution in gene therapy

4 employees · est. 2015 · Durham, United States

VS
VectorY logo

VectorY

VectorY combines the therapeutic potential of antibodies and gene therapy to develop long-lasting therapeutic solutions

114 employees · est. 2020 · Amsterdam, The Netherlands

StrideBio, Inc is the older company (2015 vs 2020); VectorY is the larger of the two.

Side-by-Side Comparison

StrideBio, Inc VectorY
Founded
2015 older 2020
Headquarters
Durham, United States Amsterdam, The Netherlands
Employees
4 114 larger
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology
Funding Stage
Acquired Series A
Total Funding
$97.20M $160.00M
Funding Rounds
5 2
Services
Development of gene therapies, AAV (Adeno-associated virus) manufacturing, Drug development for life-threatening diseases Not tracked yet
Target Customers
Patients with life-threatening diseases, Healthcare providers, Biopharmaceutical sector Not tracked yet
Taxonomy
Gene TherapyAAV VectorsGenetic MedicinesRare DiseasesVector EngineeringPre-existing Neutralizing Antibody Evasion +8 Gene TherapyAntibody TherapyVectorized AntibodiesCNS DisordersSomatic DisordersMuscle Diseases +7
Website
stridebio.com vectorytx.com
StrideBio, Inc logo

About StrideBio, Inc

StrideBio, Inc, founded in 2015, is a pioneering gene therapy company headquartered in the United States. Their slogan, "The next evolution in gene therapy," underscores their commitment to developing transformative genetic medicines. StrideBio's innovative approach addresses the challenges of first...

VectorY logo

About VectorY

VectorY is a promising player in the Biotechnology industry, leveraging the therapeutic potential of antibodies and gene therapy to address large disease areas with high unmet medical needs. Founded in August 2020 and based in the Amsterdam Science Park, this fully integrated gene therapy company is...

Also comparing in this category

Comparing more than these two?

Get StrideBio, Inc, VectorY and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.

How does StrideBio, Inc compare?

A PDF of StrideBio, Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Rival Readout

Comparing competitors? We do this properly.

10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.

Frequently Asked Questions

StrideBio, Inc was founded in 2015, based in Durham, United States, with 4 employees. StrideBio, Inc, founded in 2015, is a pioneering gene therapy company headquartered in the United States. Their slogan, "The next evolution in gene therapy," underscores their commitment to developing. VectorY was founded in 2020, based in Amsterdam, The Netherlands, with 114 employees. VectorY is a promising player in the Biotechnology industry, leveraging the therapeutic potential of antibodies and gene therapy to address large disease areas with high unmet medical needs. Founded i.
StrideBio, Inc has raised $97.20M and VectorY $160.00M. Latest stage: StrideBio, Inc Acquired, VectorY Series A.
Both work in Biotechnology and list gene therapy among their focus areas.

Compare StrideBio, Inc with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at StrideBio, Inc on 15 Jun 2026, and VectorY on 22 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout